| 12.41 -0.74 (-5.63%) | 07-18 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 16.88  |
1-year : | 18.37 |
| Resists | First : | 14.45 |
Second : | 15.72 |
| Pivot price | 13.48 |
|||
| Supports | First : | 12.38 |
Second : | 10.3 |
| MAs | MA(5) : | 13.12 |
MA(20) : | 13.59 |
| MA(100) : | 15.75 |
MA(250) : | 13.23  |
|
| MACD | MACD : | -0.5 |
Signal : | -0.5 |
| %K %D | K(14,3) : | 17.3 |
D(3) : | 21.9 |
| RSI | RSI(14): 30.6 |
|||
| 52-week | High : | 21.05 | Low : | 7.92 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ ALHC ] has closed below the lower bollinger band by 14.3%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 39.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 13.28 - 13.36 | 13.36 - 13.42 |
| Low: | 12.2 - 12.3 | 12.3 - 12.37 |
| Close: | 12.28 - 12.42 | 12.42 - 12.53 |
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada. It also coordinates and provides covered health care services, including professional, institutional, and ancillary services to members enrolled in certain benefit plans of unaffiliated Medicare Advantage Health Maintenance Organizations. The company was founded in 2013 and is based in Orange, California.
Thu, 10 Jul 2025
Alignment Healthcare, Inc. to Announce Second Quarter 2025 Financial Results on July 30 - Nasdaq
Thu, 10 Jul 2025
Alignment Healthcare to Announce Second Quarter 2025 - GlobeNewswire
Thu, 10 Jul 2025
Alignment Healthcare Sets Q2 Earnings Date: What Investors Should Mark on Their Calendar - Stock Titan
Tue, 08 Jul 2025
Medicare Quality Milestone: Alignment Healthcare Secures 4-Star Rating for All 217,500 Members - Stock Titan
Tue, 08 Jul 2025
Alignment Healthcare Wins Key Legal Victory: Arizona Medicare Advantage Plans Elevated to 4 Stars - The Globe and Mail
Tue, 08 Jul 2025
Alignment Healthcare (ALHC) Stock Trades Up, Here Is Why - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Plans
|
|
| Shares Out | 198 (M) |
| Shares Float | 145 (M) |
| Held by Insiders | 5.5 (%) |
| Held by Institutions | 92.7 (%) |
| Shares Short | 10,130 (K) |
| Shares Short P.Month | 8,890 (K) |
| EPS | -0.47 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.55 |
| Profit Margin | -3.1 % |
| Operating Margin | -0.5 % |
| Return on Assets (ttm) | -5.1 % |
| Return on Equity (ttm) | -75.4 % |
| Qtrly Rev. Growth | 47.5 % |
| Gross Profit (p.s.) | 1.75 |
| Sales Per Share | 15.16 |
| EBITDA (p.s.) | -0.18 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 58 (M) |
| Levered Free Cash Flow | 85 (M) |
| PE Ratio | -26.41 |
| PEG Ratio | 0 |
| Price to Book value | 22.56 |
| Price to Sales | 0.81 |
| Price to Cash Flow | 42.61 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|